Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1B1 | Q16678 | 5/20 | 0.67 |
| ▸ | DRD3 | P35462 | 1/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.55 |
| ▸ | HPGD | P15428 | 1/20 | 0.55 |
| ▸ | CASP1 | P29466 | 1/20 | 0.55 |
| ▸ | MPI | P34949 | 1/20 | 0.55 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.55 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.55 |
| ▸ | LMNA | P02545 | 1/20 | 0.55 |
| ▸ | MEN1 | O00255 | 1/20 | 0.55 |
| ▸ | USP2 | O75604 | 1/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.55 |
| ▸ | ATM | Q13315 | 1/20 | 0.55 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.55 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.55 |
| ▸ | CA12 | O43570 | 1/20 | 0.54 |
| ▸ | CA9 | Q16790 | 1/20 | 0.54 |
| ▸ | GLS | O94925 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL92102 | 1.00 | CYP1B1 (0.67) | CYP1B1DRD3ALDH1A1HPGDCASP1 | |
| SCHEMBL2469135 | 0.98 | CYP1B1 (0.64) | CYP1B1DRD3ALDH1A1HPGDCASP1 | |
| Water SCHEMBL3507216 | 0.98 | CYP1B1 (0.64) | CYP1B1DRD3ALDH1A1HPGDCASP1 | |
| Bromide SCHEMBL17510003 | 0.98 | CYP1B1 (0.64) | CYP1B1DRD3ALDH1A1HPGDCASP1 | |
| SCHEMBL1199669 | 0.89 | CYP1B1 (0.56) | CYP1B1DRD3ALDH1A1HPGDCASP1 | |
| Sulfuric Acid SCHEMBL29217851 | 0.89 | CYP1B1 (0.56) | CYP1B1DRD3ALDH1A1HPGDCASP1 | |
| SCHEMBL10491007 | 0.86 | CYP1B1 (0.53) | CYP1B1DRD3ALDH1A1HPGDCASP1 | |
| Ethane SCHEMBL11688465 | 0.86 | CYP1B1 (0.53) | CYP1B1DRD3ALDH1A1HPGDCASP1 | |
| SCHEMBL11445227 | 0.85 | CYP1B1 (0.52) | CYP1B1DRD3ALDH1A1HPGDCASP1 | |
| SCHEMBL15623083 | 0.85 | CYP1B1 (0.52) | CYP1B1DRD3ALDH1A1HPGDCASP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116514624-A | N-monofluoromethyl carbonyl compound and preparation method thereof | 中山大学附属第一医院 | 2023-08-01 | — | — | CN | claimed |
| US-12187742-B2 | Dual ATM and DNA-PK inhibitors for use in anti-tumor therapy | XRAD THERAPEUTICS, INC. (US) | 2025-01-07 | — | — | US | disclosed |
| CN-116514624-B | N-monofluoromethyl carbonyl compound and preparation method thereof | 中山大学附属第一医院 | 2024-07-23 | — | — | CN | disclosed |
| CN-111587239-B | Method for producing lactam compound and lactam compound produced by the method | 基础科学研究院 | 2024-04-02 | — | — | CN | disclosed |
| CN-117396474-A | Plasma kallikrein inhibitors | 武田药品工业株式会社 | 2024-01-12 | — | — | CN | disclosed |
| CN-117279924-A | Chemically-ligatable nuclear targeting tags | 西格马-奥尔德里奇有限责任公司 | 2023-12-22 | — | — | CN | disclosed |
| CN-116514624-A | N-monofluoromethyl carbonyl compound and preparation method thereof | 中山大学附属第一医院 | 2023-08-01 | — | — | CN | disclosed |
| CN-110088093-B | Acyl sulfonamide nav1.7 inhibitors | 百时美施贵宝公司 | 2023-06-13 | — | — | CN | disclosed |
| US-20220315606-A1 | DUAL ATM AND DNA-PK INHIBITORS FOR USE IN ANTI-TUMOR THERAPY | XRAD HOLDING CAYMAN LIMITED (KY) | 2022-10-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220315606-A1 | DUAL ATM AND DNA-PK INHIBITORS FOR USE IN ANTI-TUMOR THERAPY | ATM, CHEK2, CHEK1 | CYP1B1 3783/4885DRD3 4784/4885ALDH1A1 3354/4885 |
| US-12187742-B2 | Dual ATM and DNA-PK inhibitors for use in anti-tumor therapy | ATM, CHEK2, CHEK1 | CYP1B1 3783/4885DRD3 4784/4885ALDH1A1 3354/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.